1. Home
  2. PKOH vs RZLT Comparison

PKOH vs RZLT Comparison

Compare PKOH & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park-Ohio Holdings Corp.

PKOH

Park-Ohio Holdings Corp.

HOLD

Current Price

$26.30

Market Cap

299.5M

Sector

Industrials

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$3.05

Market Cap

326.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKOH
RZLT
Founded
1907
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
299.5M
326.4M
IPO Year
1994
2011

Fundamental Metrics

Financial Performance
Metric
PKOH
RZLT
Price
$26.30
$3.05
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$37.00
$9.17
AVG Volume (30 Days)
19.9K
2.4M
Earning Date
01-01-0001
05-27-2026
Dividend Yield
1.89%
N/A
EPS Growth
287.10
26.32
EPS
1.63
N/A
Revenue
$1,656,200,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.72
N/A
P/E Ratio
$16.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.52
$1.07
52 Week High
$28.50
$11.46

Technical Indicators

Market Signals
Indicator
PKOH
RZLT
Relative Strength Index (RSI) 54.87 43.63
Support Level $18.80 $2.80
Resistance Level $28.50 $4.21
Average True Range (ATR) 1.01 0.34
MACD -0.24 -0.02
Stochastic Oscillator 25.40 10.78

Price Performance

Historical Comparison
PKOH
RZLT

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: